Description: Pharma and Profits : Balancing Innovation, Medicine, and Drug Prices, Paperback by Lamattina, John L., ISBN 1119881331, ISBN-13 9781119881339, Brand New, Free shipping in the US "Despite significant recent progress, there is still one major issue facing the pharmaceutical industry that dwarfs all others -- the price of drugs, which is a unifying factor on both partisan sides in US politics. The pharmaceutical industry shouldn't be surprised by the backlash given that the media is routinely filled with high drug pricing stories: life-saving gene therapies priced at over $2 million per patient, busloads of Americans heading over the border to Canada to get insulin for their diabetes, Pfizer and Moderna justifying billions of dollars in revenues for new COVID-19 mRNA vaccines. This book seeks to answer these and other questions -- is the drug industry filled with profiteers "getting away with murder" or is it an industry made up ofcompanies that invest in a high-risk business called "innovation" that makes modest returns on capital at risk?"--
Price: 24.64 USD
Location: Jessup, Maryland
End Time: 2025-02-03T11:05:07.000Z
Shipping Cost: 0 USD
Product Images
Item Specifics
Return shipping will be paid by: Buyer
All returns accepted: Returns Accepted
Item must be returned within: 14 Days
Refund will be given as: Money Back
Return policy details:
Book Title: Pharma and Profits : Balancing Innovation, Medicine, and Drug Pri
Number of Pages: 112 Pages
Language: English
Publication Name: Pharma and Profits : Balancing Innovation, Medicine, and Drug Prices
Publisher: Wiley & Sons, Incorporated, John
Item Height: 0.3 in
Subject: Industries / Pharmaceutical & Biotechnology, Pharmacology, Economics / General, Chemistry / General
Publication Year: 2022
Type: Textbook
Item Weight: 4.8 Oz
Subject Area: Science, Business & Economics, Medical
Item Length: 8.9 in
Author: John L. Lamattina
Item Width: 5.9 in
Format: Trade Paperback
